1. Home
  2. CCCC vs RELL Comparison

CCCC vs RELL Comparison

Compare CCCC & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • RELL
  • Stock Information
  • Founded
  • CCCC 2015
  • RELL 1947
  • Country
  • CCCC United States
  • RELL United States
  • Employees
  • CCCC N/A
  • RELL N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • RELL Electronic Components
  • Sector
  • CCCC Health Care
  • RELL Technology
  • Exchange
  • CCCC Nasdaq
  • RELL Nasdaq
  • Market Cap
  • CCCC 115.0M
  • RELL 127.4M
  • IPO Year
  • CCCC 2020
  • RELL N/A
  • Fundamental
  • Price
  • CCCC $1.47
  • RELL $9.00
  • Analyst Decision
  • CCCC Buy
  • RELL
  • Analyst Count
  • CCCC 3
  • RELL 0
  • Target Price
  • CCCC $12.00
  • RELL N/A
  • AVG Volume (30 Days)
  • CCCC 943.9K
  • RELL 37.5K
  • Earning Date
  • CCCC 07-31-2025
  • RELL 07-23-2025
  • Dividend Yield
  • CCCC N/A
  • RELL 2.65%
  • EPS Growth
  • CCCC N/A
  • RELL N/A
  • EPS
  • CCCC N/A
  • RELL N/A
  • Revenue
  • CCCC $39,783,000.00
  • RELL $204,394,000.00
  • Revenue This Year
  • CCCC N/A
  • RELL $9.48
  • Revenue Next Year
  • CCCC N/A
  • RELL $4.10
  • P/E Ratio
  • CCCC N/A
  • RELL N/A
  • Revenue Growth
  • CCCC 98.56
  • RELL N/A
  • 52 Week Low
  • CCCC $1.09
  • RELL $7.57
  • 52 Week High
  • CCCC $7.66
  • RELL $15.51
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 51.01
  • RELL 46.97
  • Support Level
  • CCCC $1.21
  • RELL $8.66
  • Resistance Level
  • CCCC $1.57
  • RELL $9.18
  • Average True Range (ATR)
  • CCCC 0.12
  • RELL 0.22
  • MACD
  • CCCC 0.02
  • RELL 0.02
  • Stochastic Oscillator
  • CCCC 70.27
  • RELL 36.96

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.

Share on Social Networks: